Strength
100 mg/1
Manufacturer
Allergan, Inc.NDC
00023650110
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
1/2/2026
Active Ingredients
UBROGEPANTApproval Type
New Drug (NDA)
FDA Application
NDA211765On Market Since
12/23/2019
Pharmacological Classes
Calcitonin Gene-related Peptide Receptor Antagonist
Calcitonin Gene-related Peptide Receptor Antagonists
Related Drugs
Same classification
QULIPTA 10 MG TABLET
Brand
00074709530•AbbVie Inc.
$38.3668
per EA
QULIPTA 30 MG TABLET
Brand
00074709630•AbbVie Inc.
$38.4048
per EA
QULIPTA 60 MG TABLET
Brand
00074709430•AbbVie Inc.
$38.4749
per EA
NURTEC ODT 75 MG TABLET
Brand
72618300002•Pfizer Inc.
$128.7461
per EA
ZAVZPRET 10 MG NASAL SPRAY
Brand
00069350002•Pfizer Inc.
$190.1660
per EA